Premium
Pegylated interferon‐alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
Author(s) -
Annicchiarico B. E.,
Siciliano M.
Publication year - 2004
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2004.01954.x
Subject(s) - ribavirin , medicine , pegylated interferon , gastroenterology , interferon , renal function , dialysis , hemodialysis , pegylation , alpha interferon , hepatitis c , kidney disease , adverse effect , liver disease , hepatitis c virus , immunology , virus , peg ratio , finance , economics